TheJobsMapNRx Pharmaceuticals jobs and careers
Wilmington, DE, United States
About NRx Pharmaceuticals
NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.
Founded in 2015 by Daniel Javitt, Jonathan C. Javitt, RICHARD C. SIEGEL and Robert Besthof.
- Founded
- 2015
- Employees
- 11 to 50
- Total funding
- $119M
- Headquarters
- Wilmington
Leadership
The top of NRx Pharmaceuticals's org chart, with how many people report into each leader.
Martin Brecher
Medical Director
2 reports
Dennis K. McBride
Chief Strategy Officer & Senior Scientist
2 reports
Jonathan C. Javitt
Founder & Chief Scientist
Philip T. Lavin
Chief Methodologist
M. Daniel Gordin
Regulatory Affairs Officer
Matthew Duffy
Chief Business Officer
Rick Panicucci
Chief Technology Officer
Cortney Kolesar
Associate Clinical Rater
Michael Sapko
Director of Medical Writing
Zachary Javitt
Director Of Brand Strategy
1 report
Board
Chaim Hurvitz
Director
Patrick Flynn
Board Member
Harry B. Peled
Clinical Advisor COVID-19
Wayne Pines
Regulatory & Patient Advocacy Adviser
Sherry A. Glied
Director
Daniel C. Javitt
Co-Founder & Chair, Scientific Advisory Board
Jobs at NRx Pharmaceuticals
No open positions right now. Explore more companies on TheJobsMap.